These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7925293)

  • 21. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
    Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and molecular cloning of SH2- and SH3-containing inositol polyphosphate-5-phosphatase, which is involved in the signaling pathway of granulocyte-macrophage colony-stimulating factor, erythropoietin, and Bcr-Abl.
    Odai H; Sasaki K; Iwamatsu A; Nakamoto T; Ueno H; Yamagata T; Mitani K; Yazaki Y; Hirai H
    Blood; 1997 Apr; 89(8):2745-56. PubMed ID: 9108392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The oncogenic 70Z Cbl mutation blocks the phosphotyrosine binding domain-dependent negative regulation of ZAP-70 by c-Cbl in Jurkat T cells.
    van Leeuwen JE; Paik PK; Samelson LE
    Mol Cell Biol; 1999 Oct; 19(10):6652-64. PubMed ID: 10490604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.
    Allen PB; Morgan GJ; Wiedemann LM
    Baillieres Clin Haematol; 1992 Oct; 5(4):897-930. PubMed ID: 1308169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
    Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ
    Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ras-dependent, Ca2+-stimulated activation of nuclear factor of activated T cells by a constitutively active Cbl mutant in T cells.
    Liu YC; Elly C; Langdon WY; Altman A
    J Biol Chem; 1997 Jan; 272(1):168-73. PubMed ID: 8995243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of a novel, transforming allele of the c-Cbl proto-oncogene from a murine macrophage cell line.
    Bisson SA; Ujack EE; Robbins SM
    Oncogene; 2002 May; 21(23):3677-87. PubMed ID: 12032836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation.
    Galisteo ML; Dikic I; Batzer AG; Langdon WY; Schlessinger J
    J Biol Chem; 1995 Sep; 270(35):20242-5. PubMed ID: 7657591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Cbl is inducibly tyrosine-phosphorylated by epidermal growth factor stimulation in fibroblasts, and constitutively tyrosine-phosphorylated and associated with v-Src in v-src-transformed fibroblasts.
    Odai H; Sasaki K; Hanazono Y; Ueno H; Tanaka T; Miyagawa K; Mitani K; Yazaki Y; Hirai H
    Jpn J Cancer Res; 1995 Dec; 86(12):1119-26. PubMed ID: 8635998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Cbl protooncogene product: from an enigmatic oncogene to center stage of signal transduction.
    Miyake S; Lupher ML; Andoniou CE; Lill NL; Ota S; Douillard P; Rao N; Band H
    Crit Rev Oncog; 1997; 8(2-3):189-218. PubMed ID: 9570294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential.
    Franz WM; Berger P; Wang JY
    EMBO J; 1989 Jan; 8(1):137-47. PubMed ID: 2496972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosine phosphorylation of C-Cbl facilitates adhesion and spreading while suppressing anchorage-independent growth of V-Abl-transformed NIH3T3 fibroblasts.
    Feshchenko EA; Shore SK; Tsygankov AY
    Oncogene; 1999 Jun; 18(25):3703-15. PubMed ID: 10391678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl.
    Salgia R; Sattler M; Pisick E; Li JL; Griffin JD
    Exp Hematol; 1996 Feb; 24(2):310-3. PubMed ID: 8641358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of nuclear factor of activated T cells-(NFAT) and activating protein 1 (AP-1) by oncogenic 70Z Cbl requires an intact phosphotyrosine binding domain but not Crk(L) or p85 phosphatidylinositol 3-kinase association.
    van Leeuwen JE; Paik PK; Samelson LE
    J Biol Chem; 1999 Feb; 274(8):5153-62. PubMed ID: 9988765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas.
    Langdon WY; Hartley JW; Klinken SP; Ruscetti SK; Morse HC
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1168-72. PubMed ID: 2784003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.
    Muller AJ; Young JC; Pendergast AM; Pondel M; Landau NR; Littman DR; Witte ON
    Mol Cell Biol; 1991 Apr; 11(4):1785-92. PubMed ID: 2005881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the tyrosine kinase inhibitor imatinib mesylate on a Bcr-Abl-positive cell line: suppression of autonomous cell growth but no effect on decreased adhesive property and morphological changes.
    Nishihara T; Miura Y; Tohyama Y; Mizutani C; Hishita T; Ichiyama S; Uchiyama T; Tohyama K
    Int J Hematol; 2003 Oct; 78(3):233-40. PubMed ID: 14604282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Cbl-facilitated cytoskeletal effects in v-Abl-transformed fibroblasts are regulated by membrane association of c-Cbl.
    Swaminathan G; Feshchenko EA; Tsygankov AY
    Oncogene; 2007 Jun; 26(28):4095-105. PubMed ID: 17237826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis.
    Cortez D; Kadlec L; Pendergast AM
    Mol Cell Biol; 1995 Oct; 15(10):5531-41. PubMed ID: 7565705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of change in phosphorylation of BCR-ABL kinase and its substrates in response to Imatinib treatment in human chronic myelogenous leukemia cells.
    Liang X; Hajivandi M; Veach D; Wisniewski D; Clarkson B; Resh MD; Pope RM
    Proteomics; 2006 Aug; 6(16):4554-64. PubMed ID: 16858728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.